Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30000313
Basic Information
VIS ID
TVIS30000313
Fusion event
HIV-CABP4 integration
Validated
No
Detection method
NG-SGS
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2018
PubMed ID
30024859
Virus Sequence
Virus name
HIV
Reference genome
K03455.1
Host Sequence
Chromosome
chr11
Cytoband
q13.2
Reference genome
GRCh37/hg19
Start
67220490/67453019 (Hg38)
End
67220490/67453019 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA11H
Target gene
CABP4
miRNAs that regulate target gene
hsa-mir-3689d
;
hsa-mir-6819-5p
;
hsa-mir-6737-5p
;
hsa-mir-6812-5p
;
hsa-mir-1178-3p
;
hsa-mir-106a-3p
;
hsa-mir-7641
;
hsa-mir-3650
;
hsa-mir-6747-5p
;
hsa-mir-608
;
hsa-mir-4651
;
hsa-mir-4664-5p
;
hsa-mir-342-5p
;
hsa-mir-5787
;
hsa-mir-4505
;
hsa-mir-4731-5p
;
hsa-mir-3934-3p
;
hsa-mir-4695-3p
;
hsa-mir-6787-3p
;
hsa-mir-7155-5p
;
hsa-mir-484
;
hsa-mir-3155b
;
hsa-mir-3155a
;
hsa-mir-574-5p
;
hsa-mir-190a-3p
;
hsa-mir-6867-5p
;
hsa-mir-223-5p
;
hsa-mir-5011-5p
;
hsa-mir-410-3p
;
hsa-mir-3163
;
hsa-mir-4687-3p
;
hsa-mir-7974
;
hsa-mir-889-5p
;
hsa-mir-6759-3p
;
hsa-mir-6873-3p
;
hsa-mir-6826-3p
;
hsa-mir-1236-3p
;
hsa-mir-6515-3p
;
hsa-mir-6817-3p
;
hsa-mir-7110-3p
;
hsa-mir-6832-3p
;
hsa-mir-6756-3p
;
hsa-mir-3127-3p
;
hsa-mir-3152-5p
;
hsa-mir-6809-3p
;
hsa-mir-6836-3p
;
hsa-mir-4753-3p
;
hsa-mir-6783-3p
;
hsa-mir-1343-3p
;
hsa-mir-23b-5p
;
hsa-mir-23a-5p
;
hsa-mir-6829-3p
;
hsa-mir-6791-3p
;
hsa-mir-2276-3p
;
hsa-mir-1304-3p
;
hsa-mir-1281
;
hsa-mir-6742-3p
;
hsa-mir-6852-5p
;
hsa-mir-939-3p
;
hsa-mir-4485-5p
;
hsa-mir-6890-3p
;
hsa-mir-122-3p
;
hsa-mir-6807-5p
;
hsa-mir-7977
;
hsa-mir-5685
;
hsa-mir-4690-3p
;
hsa-mir-6878-3p
;
hsa-mir-6744-3p
;
hsa-mir-4757-5p
;
hsa-mir-3922-3p
;
hsa-mir-3176
;
hsa-mir-1976
;
hsa-mir-8073
;
hsa-mir-221-5p
;
hsa-mir-6747-3p
;
hsa-mir-6727-3p
;
hsa-mir-4722-3p
;
hsa-mir-660-3p
;
hsa-mir-5193
;
hsa-mir-6513-3p
;
hsa-mir-8079
;
hsa-mir-1245a
;
hsa-mir-6877-3p
;
hsa-mir-6819-3p
;
hsa-mir-6738-3p
;
hsa-mir-5001-3p
;
hsa-mir-4727-5p
;
hsa-mir-6749-3p
;
hsa-mir-18a-3p
;
hsa-mir-324-3p
;
hsa-mir-1913
Nearest miRNA
hsa-mir-10392/Upstream/407311; hsa-let-7a-2/Downstream/37226;
Nearest TSS
ENST00000527297/Upstream/281;
ENST00000545777/Downstream/2328;
Nearest CpG islands
None/Target,
chr11-CpG: 30/Upstream/9166
,
chr11-CpG: 43/Downstream/11556
Upstream sequence
TACAATCTACTTTACAGGCGAGGACAGGAAGGTTCAGAGAATCAGTGAAGGTAGGAAGGGAGGTGCCAGGGCTCAACCCAGACttttcttttcttttctt
Downstream sequence
tttttttttttgagagacagggccttgctctattgcccaggatgagtgcagtggcacagtccctgcagcttccacctcctgggttccagcgaccctccca
Reference
Sharaf, R., et al.HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest,2018,128(9): 4074-4085.
Sample Information
×
Sample name
1C116
Sample type
PBMC
Age
44
Gender
Male
CpG Island Information
×
Download
Curate